The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

Part of paid clinical trials in Piscataway, New Jersey.

Sponsor
Rutgers, The State University of New Jersey
Study ID
NCT02447861
Status
Recruiting
Apply to this trial

Conditions

  • Microdeletion 3q29 Syndrome
  • Microduplication 3q29 Syndrome

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Study Details

The 3q29 deletion syndrome is caused by a deletion of a small part of human chromosome 3, and the duplication syndrome is caused by a duplication of this same small region. The purpose of this study is to understand the medical and behavioral consequences of these syndromes.

Key Dates

Start date
Jul 31, 2013
Status verified
May 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
800 participants (estimated)

Arms

  • Arm: 3q29 deletion
    Individuals with 3q29 deletion syndrome (sometimes called "3q29 micro deletion")
  • Arm: 3q29 duplication
    Individuals with 3q29 duplication syndrome (sometimes called "3q29 micro duplication")
  • Arm: Parents
    parents of individuals with the 3q29 deletion or 3q29 duplication
  • Arm: Healthy Controls
    Unrelated age-matched controls without 3q29 deletion or duplication

Primary Outcome Measure

Range of medical conditions associated with the 3q29 deletion and duplication, assessed by the percent of patients reporting specific conditions present [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Internet-BasedPiscatawayNew Jersey08854
Jennifer Mulle, MHS, PhD
[email protected]
(848) 445-9866
Teresa Irving, MSW
[email protected]

Find similar trials in Piscataway, NJ

By research site
Internet-Based· Piscataway, NJ